SCOPE OF THE JOURNAL
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted.
In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity. The articles published in Medical Mycology are intended to provide comprehensive information about areas at the forefront of mycological research and therapy, as well as reference concepts for use by medical and veterinary mycologists, microbiologists, clinicians, medical technologists, epidemiologists, mycotoxicologists and environmental specialists.
Authors should observe high standards with respect to publication ethics as set out by the Commission on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) . Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of the work are all unacceptable practices. Any cases of ethical misconduct are treated very seriously and will be dealt with in accordance with the COPE guidelines.
1. Humans in Research
When reporting investigations involving human subjects , authors must indicate in the manuscript if the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation within their institutions and/or with the Helsinki Declaration of 1975, as revised in 1983.
2. Animals in Research
Manuscripts containing information related to the experimental use of animals must clearly state that the studies complied with relevant professional and institutional animal welfare policies. Specifically, that procedures involving animals conformed to the Guide for the Care and Use of Laboratory Animals ( 2011 or later editions ) of the Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council.
3. Authorship Contributions
Please note that in submitting this manuscript you and your co-authors are confirming that all authors have, in accord with the Committee on Publication Ethics guidelines, (a) made a substantial contribution to the conception and design, acquisition of data, and/or analysis and interpretation of data, (b) participated in the drafting of the article or revising it critically for important intellectual content, (c) have read and approved the final manuscript, AND (d) that the manuscript is not, either in whole or in part, currently under consideration by any other scientific journal and has not been previously published in either hard copy or electronic format. Except for those submitting the manuscript, members of Study Groups should not be individually cited as authors.
Submissions with ten or more authors will ONLY be considered if the corresponding authors provide, in their cover letters, descriptions of each of the author’s contributions. Manuscripts drafted or written, in whole or part, by individuals other than those indicated as authors will NOT be considered for publication unless the contributions of these individuals are clearly and accurately presented in the Acknowledgment section of the paper.
The work of other individuals who assisted in the studies or in the preparation of the submission must be specifically indicated in the Acknowledgment section of the paper. All sources of grant funding must be given and grant numbers given. See Manuscript Preparation for additional details.
5. Disclosures of Potential Conflicts of Interest
Although there is no standard definition of Conflict of Interest, the United States National Institutes of Health has published the following statement:
It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership) that may be perceived as potentially affecting the conduct or reporting of the work submitted. All sources of funding are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure (i.e., when in doubt, provide full disclosure).
In addition, a conflict of interest may be perceived to exist in such situations as when authors are affiliated with or employed by a private enterprise whose product or competitor’s product, e.g., drug, device or diagnostic kit, is the focal point of the paper. See Manuscript Preparation for additional details.
Information about potential conflict of interest must be clearly stated at the point of submission. This may be made available to reviewers and may be published with the manuscript at the discretion of the Editors and Publisher. The journal recommends that you and your co-authors include the sub header, ‘Conflict of Interest’, in the Acknowledgment section at the end of your manuscript. If no such conflict exists, simply respond ‘None’. If you or your co-authors have received funding that meets the criteria described in the paragraph above, the source(s) of the funds must be declared (NOTE – you are NOT required to disclose the amounts of funding that you or your co-authors have received). Furthermore, authors must indicate their employment if describing their or other companies’ products.
The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.